ASH 2021 Focus on GVHD for Pharmacists

Advertisement
DocWire News EditorsASH Annual Meeting and Exposition 2021 | April 24, 2023
Patients with hematologic malignancies who may require blood transfusions may not be able to enroll in hospice care ...
Read More
DocWire News EditorsASH Annual Meeting and Exposition 2021 | April 24, 2023
Updated results from a real-world analysis confirm that ruxolitinib is an effective treatment option for patients with ...
DocWire News EditorsASH Annual Meeting and Exposition 2021 | August 25, 2023
Prophylactic treatment with subcutaneous fitusiran administered once-monthly reduced bleeding risk in patients with ...
DocWire News EditorsASH Annual Meeting and Exposition 2021 | April 24, 2023
According to a poster presented at the 2021 ASH Annual Meeting by Maria Queralt Salas, MD, from the Hospital Clinic of ...
DocWire News EditorsASH Annual Meeting and Exposition 2021 | July 5, 2023
The combination of daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell ...
DocWire News EditorsASH Annual Meeting and Exposition 2021 | April 24, 2023
Prescribing chemotherapy is not a universal practice of advanced practice providers (APPs) in the oncology community, ...
Advertisement
Advertisement
Advertisement
Latest News

March 14, 2025